Nutex Health (NUTX) Non-Current Deferred Tax Liability (2021 - 2026)

Nutex Health has reported Non-Current Deferred Tax Liability for 6 years, with the latest figure at $8.2 million in Q1 2026.

• Quarterly Non-Current Deferred Tax Liability changed N/A year-over-year to $8.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.2 million (changed N/A YoY) and the FY2025 annual result came in at $9.1 million, down 86.15% from the prior year.
• Non-Current Deferred Tax Liability fell to $8.2 million in Q1 2026 per NUTX's latest filing, from $9.1 million in the prior quarter.
• Over five years, Non-Current Deferred Tax Liability peaked at $65.6 million in Q4 2024 and troughed at $1.7 million in Q1 2022.
• A 5-year average of $15.8 million and a median of $8.8 million in 2022 frame the typical range for Non-Current Deferred Tax Liability.
• The sharpest annual moves came in 2022 and 2025: Non-Current Deferred Tax Liability jumped 619.07% in 2022, then plunged 86.15% in 2025.
• Over 5 years, Non-Current Deferred Tax Liability stood at $10.5 million in 2022, then jumped by 503.97% to $63.1 million in 2023, then rose by 3.92% to $65.6 million in 2024, then slumped by 86.15% to $9.1 million in 2025, then slipped by 10.25% to $8.2 million in 2026.
• According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $8.2 million, $9.1 million, and $15.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.